Abbott, the global healthcare leader dedicated to helping people live more fully at all stages of life, has secured $250.0M in Series d funding. The substantial capital raise underscores the company's continued financial strength as it operates across a broad spectrum of healthcare.
With a portfolio of life-changing technologies spanning diagnostics, medical devices, nutritionals, and branded generic medicines, Abbott employs 122,000 colleagues and serves people in more than 160 countries, solidifying its position as a major player in the global health sector.
